Melanoma and lymphocyte cell-specific targeting incorporated into a heat shock protein cage architecture

被引:118
作者
Flenniken, ML
Willits, DA
Harmsen, AL
Liepold, LO
Harmsen, AG
Young, MJ
Douglas, T
机构
[1] Montana State Univ, Ctr Bioinspired Nanomat, Bozeman, MT 59717 USA
[2] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA
[3] Montana State Univ, Dept Plant Sci, Bozeman, MT 59717 USA
[4] Montana State Univ, Vet Mol Biol Dept, Bozeman, MT 59717 USA
[5] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA
来源
CHEMISTRY & BIOLOGY | 2006年 / 13卷 / 02期
关键词
D O I
10.1016/j.chembiol.2005.11.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein cages, including viral capsids, ferritins, and heat shock proteins (Hsps), can serve as nanocontainers for biomedical applications. They are genetically and chemically malleable platforms, with potential as therapeutic and imaging agent delivery systems. Here, both genetic and chemical strategies were used to impart cell-specific targeting to the Hsp cage from Methanococcus jannaschii. A tumor vasculature targeting peptide was incorporated onto the exterior surface of the Hsp cage. This protein cage bound to alpha(v)beta(3) integrin-expressing cells. Cellular tropism was also imparted by conjugating anti-CD4 antibodies to the exterior of Hsp cages. These Ab-Hsp cage conjugates specifically bound to CD4(+) cells. Protein cages have the potential to simultaneously incorporate multiple functionalities, including cell-specific targeting, imaging, and therapeutic agent delivery. We demonstrate the simultaneous incorporation of two functionalities, imaging and cell-specific targeting, onto the Hsp protein cage.
引用
收藏
页码:161 / 170
页数:10
相关论文
共 101 条
  • [11] BRASLAWSKY GR, 1990, CANCER RES, V50, P6608
  • [12] ADRIAMYCIN(HYDRAZONE)-ANTIBODY CONJUGATES REQUIRE INTERNALIZATION AND INTRACELLULAR ACID-HYDROLYSIS FOR ANTITUMOR-ACTIVITY
    BRASLAWSKY, GR
    KADOW, K
    KNIPE, J
    MCGOFF, K
    EDSON, M
    KANEKO, T
    GREENFIELD, RS
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 33 (06) : 367 - 374
  • [13] Nanoparticles in cancer therapy and diagnosis
    Brigger, I
    Dubernet, C
    Couvreur, P
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) : 631 - 651
  • [14] ANTIINTEGRIN ALPHA-V-BETA-3 BLOCKS HUMAN BREAST-CANCER GROWTH AND ANGIOGENESIS IN HUMAN SKIN
    BROOKS, PC
    STROMBLAD, S
    KLEMKE, R
    VISSCHER, D
    SARKAR, FH
    CHERESH, DA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) : 1815 - 1822
  • [15] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS
    BROOKS, PC
    MONTGOMERY, AMP
    ROSENFELD, M
    REISFELD, RA
    HU, TH
    KLIER, G
    CHERESH, DA
    [J]. CELL, 1994, 79 (07) : 1157 - 1164
  • [16] Hitting the target with bifunctional phage
    Brown, KC
    [J]. CHEMISTRY & BIOLOGY, 2004, 11 (08): : 1033 - 1035
  • [17] MAGNETOFERRITIN - BIOMINERALIZATION AS A NOVEL MOLECULAR APPROACH IN THE DESIGN OF IRON-OXIDE-BASED MAGNETIC-RESONANCE CONTRAST AGENTS
    BULTE, JWM
    DOUGLAS, T
    MANN, S
    FRANKEL, RB
    MOSKOWITZ, BM
    BROOKS, RA
    BAUMGARNER, CD
    VYMAZAL, J
    FRANK, JA
    [J]. INVESTIGATIVE RADIOLOGY, 1994, 29 : S214 - S216
  • [18] MAGNETOFERRITIN - CHARACTERIZATION OF A NOVEL SUPERPARAMAGNETIC MR CONTRAST AGENT
    BULTE, JWM
    DOUGLAS, T
    MANN, S
    FRANKEL, RB
    MOSKOWITZ, BM
    BROOKS, RA
    BAUMGARNER, CD
    VYMAZAL, J
    STRUB, MP
    FRANK, JA
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 1994, 4 (03) : 497 - 505
  • [19] Burke PA, 2002, CANCER RES, V62, P4263
  • [20] Burkhart DJ, 2004, MOL CANCER THER, V3, P1593